BULLETIN V2026-2346
VOYAGEUR PHARMACEUTICALS LTD. ("VM")
BULLETIN TYPE: Private Placement-Non-Brokered
BULLETIN DATE: July 15, 2026
TSX Venture Tier 2 Company
Financing Type: Non-Brokered Private Placement
Gross Proceeds: $5,005,278.32
Offering: 15,931,486 flow-through listed shares (the "FT Listed Shares") with 15,931,486 flow-through warrants (the "FT Warrants") attached
30,935,000 listed shares (the "Listed Shares") with 30,935,000 warrants (the "Warrants") attached
Offering Price: $0.12 per FT Listed Share
$0.10 per Listed Share
Warrant Exercise Terms: $0.20 per FT Warrant for a period of 36 months from date of issuance, subject to an acceleration provision.
$0.20 per Warrant for a period of 36 months from date of issuance, subject to an acceleration provision.
Non-Cash Commissions: Units Warrants
Finders (Aggregate) N/A 1,215,019 (FT)
N/A 1,920,400
Commission Terms:
Each non-transferrable flow-through broker's warrant (the "FT Broker's Warrant") is exercisable at $0.12 for a period of 12 months from the date of issuance.
Each non-transferrable broker's warrant (the "Broker's Warrant") is exercisable at $0.10 for a period of 12 months from the date of issuance.
Public Disclosure: Refer to the company's news release(s) dated May 1, 2026, May 28, 2026 and June 5, 2026.
_______________________________________
|
|
